Carine van den Brink is a lawyer specialized in transactions in the life sciences. In her work she combines here over 30 years of experience as a transaction lawyer with her medical background. Carine has an in-depth knowledge of the biotech and technology markets as lawyer, in-house counsel and supervisory board member. The areas of expertise of her group within Axon include private equity financing, intellectual property licensing, M&A, research and development driven contracts, pharmaceutical contracts and regulatory advice. Carine guides her clients from the crib to their exit, including spinning out businesses from universities, obtaining financing (equity, loans, or subsidies), securing strategic partners, intellectual property exploitation, clinical development, market approval, and commercialisation.